The use of implantable cardioverter defibrillators in Iceland: a retrospective population based study
2006

Use of Implantable Cardioverter Defibrillators in Iceland

Sample size: 62 publication Evidence: moderate

Author Information

Author(s): Leosdottir Margret, Reimarsdottir Gudrun, Gottskalksson Gizur, Torfason Bjarni, Vigfusdottir Margret, Arnar David O

Primary Institution: Landspitali University Hospital

Hypothesis

The study aims to review the overall experience with ICDs in Iceland.

Conclusion

The experience with ICDs in Iceland is similar to that in other Western countries.

Supporting Evidence

  • The mean age at implantation was 58 years.
  • Forty patients (65%) had coronary artery disease.
  • The most common indications for ICD implantation were cardiac arrest and ventricular tachycardia.
  • Inappropriate shocks were the most common long-term adverse event.

Takeaway

This study looked at how many people in Iceland got heart devices to help with dangerous heart rhythms, and found that their experiences are like those in other countries.

Methodology

A retrospective single center study reviewing all ICD implantations in Iceland from 1992 to 2002.

Limitations

The study's major limitation is its small sample size and retrospective design.

Participant Demographics

{"mean_age":58,"gender_distribution":{"male":71,"female":29},"underlying_conditions":{"coronary_artery_disease":65,"dilated_cardiomyopathy":11,"ventricular_tachycardia_without_known_cardiac_illness":11,"long_QT_syndrome":10,"hypertrophic_cardiomyopathy":2,"suspected_drug_related_ventricular_arrhythmia":2,"coronary_artery_spasm":2,"cardiac_amyloidosis":2}}

Digital Object Identifier (DOI)

10.1186/1471-2261-6-22

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication